Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
1.120
-0.070 (-5.88%)
Dec 17, 2025, 11:29 AM EST - Market open
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $35.9 million as of December 17, 2025. Its market cap has decreased by -73.64% in one year.
Market Cap
35.90M
Enterprise Value
3.16M
1-Year Change
-73.64%
Ranking
Category
Stock Price
$1.12
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $35.90M, a decrease of -89.92%. That is a compound annual growth rate of -74.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 38.10M | -55.65% |
| Dec 31, 2024 | 85.90M | -75.88% |
| Apr 11, 2024 | 356.10M | - |
View and export this data all the way back to 2024. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 943.99B |
| Johnson & Johnson | 504.27B |
| AbbVie | 395.31B |
| UnitedHealth Group | 302.73B |
| AstraZeneca | 281.22B |
| Novartis AG | 259.57B |
| Merck & Co. | 243.91B |
| Abbott Laboratories | 220.59B |